...
首页> 外文期刊>Osteoporosis and Sarcopenia >Long-term changes in lean mass in postmenopausal women and the effects of osteoporosis pharmacotherapy: A 10-year longitudinal study
【24h】

Long-term changes in lean mass in postmenopausal women and the effects of osteoporosis pharmacotherapy: A 10-year longitudinal study

机译:绝经后妇女的瘦松群的长期变化及骨质疏松药物治疗的影响:10年纵向研究

获取原文
           

摘要

ObjectivesAlthough sarcopenia is diagnosed using appendicular lean mass (ALM), only a few long-term studies on changes in both ALM and bone mineral density (BMD) have been reported. The purposes of this study are to evaluate the changes in the parameters of lean mass and bone mass over a 10-year interval and to estimate the effects of osteoporosis pharmacotherapy on muscle.MethodsA total of 175 postmenopausal women were evaluated at baseline and after 10 years for BMD, ALM, fat mass, height, and weight. Subjects were further divided into an osteoporosis treatment group (n?=?60) and a control group (n?=?67) according to whether they had received pharmacotherapy for?>?5 years. This was followed by propensity score matching for age, height, weight, and body mass index (BMI), and estimated parameters were compared between groups.ResultsHeight, weight, ALM, and fat mass decreased significantly over 10 years (P?
机译:虽然使用阑尾稀质量(ALM)诊断出肌肉细胞,但已经报道了几种关于ALM和骨密度(BMD)的变化的长期研究。本研究的目的是评估10年间隔内贫民和骨质和骨质的参数的变化,并估计骨质疏松药物治疗对肌肉的影响。在基线和10年后评估了175名绝经后妇女的方法。用于BMD,ALM,脂肪质量,高度和重量。根据他们是否接受药物治疗,进一步分为骨质疏松治疗组(N?=Δ60)和对照组(N?=Δ67)的骨质疏松症治疗组(N?=?67)。接下来是倾达评分匹配年龄,高度,重量和体重指数(BMI),比较估计的参数在群之间进行比较。方法,重量,ALM和脂肪量明显减少(P?<?0.05 )。然而,倾斜质量指数(LMI),衍生为ALM除以高度平方,显着增加(P?<0.001)。 BMD随骨质疏松症治疗(P?<〜0.05)显着增加,而骨质疏松症治疗和对照组在对ALM或脂肪质量的变化中没有显着差异。结论,LMI显着增加。这种矛盾的结果似乎受年龄相关的高度损失的影响。因此,当使用LMI纵向评估SARCOPENIA时需要考虑高度损失的效果。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号